

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pattern specification involved in kidney development (GO:0061004) | 5.87985400 |
| 2 | regulation of T-helper 2 cell differentiation (GO:0045628) | 5.70993502 |
| 3 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.51652912 |
| 4 | negative regulation of sodium ion transport (GO:0010766) | 4.84252842 |
| 5 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.71524204 |
| 6 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.71524204 |
| 7 | positive regulation of T cell cytokine production (GO:0002726) | 4.66617623 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 4.65702414 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 4.65702414 |
| 10 | tryptophan catabolic process (GO:0006569) | 4.65702414 |
| 11 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.52328120 |
| 12 | kynurenine metabolic process (GO:0070189) | 4.45727825 |
| 13 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.28444915 |
| 14 | sperm motility (GO:0030317) | 4.22741139 |
| 15 | cellular response to exogenous dsRNA (GO:0071360) | 4.07661917 |
| 16 | phosphate ion homeostasis (GO:0055062) | 4.02294004 |
| 17 | trivalent inorganic anion homeostasis (GO:0072506) | 4.02294004 |
| 18 | oligosaccharide catabolic process (GO:0009313) | 3.91728702 |
| 19 | response to pheromone (GO:0019236) | 3.91014942 |
| 20 | regulation of memory T cell differentiation (GO:0043380) | 3.88443979 |
| 21 | positive regulation of type 2 immune response (GO:0002830) | 3.84572969 |
| 22 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.76582494 |
| 23 | cellular anion homeostasis (GO:0030002) | 3.76547731 |
| 24 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.75628270 |
| 25 | intestinal cholesterol absorption (GO:0030299) | 3.70814519 |
| 26 | regulation of regulatory T cell differentiation (GO:0045589) | 3.68572350 |
| 27 | natural killer cell activation involved in immune response (GO:0002323) | 3.67976075 |
| 28 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.63479288 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 3.57891213 |
| 30 | sulfation (GO:0051923) | 3.50558038 |
| 31 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.50496206 |
| 32 | tryptophan metabolic process (GO:0006568) | 3.49807392 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 3.37433312 |
| 34 | plasma membrane fusion (GO:0045026) | 3.37432671 |
| 35 | low-density lipoprotein particle remodeling (GO:0034374) | 3.34662496 |
| 36 | regulation of T cell cytokine production (GO:0002724) | 3.32820451 |
| 37 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.31669561 |
| 38 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.31000120 |
| 39 | axonemal dynein complex assembly (GO:0070286) | 3.30467458 |
| 40 | peroxisome fission (GO:0016559) | 3.27154884 |
| 41 | membrane protein intracellular domain proteolysis (GO:0031293) | 3.24825170 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 3.14564664 |
| 43 | macromolecular complex remodeling (GO:0034367) | 3.14564664 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.14564664 |
| 45 | spermatid development (GO:0007286) | 3.13670468 |
| 46 | regulation of somitogenesis (GO:0014807) | 3.12035421 |
| 47 | acrosome assembly (GO:0001675) | 3.10898805 |
| 48 | cellular response to prostaglandin stimulus (GO:0071379) | 3.07672116 |
| 49 | regulation of T-helper 1 type immune response (GO:0002825) | 3.06076906 |
| 50 | glomerular basement membrane development (GO:0032836) | 3.00580926 |
| 51 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98172778 |
| 52 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95118247 |
| 53 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.94740756 |
| 54 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.91424443 |
| 55 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.89851068 |
| 56 | regulation of interleukin-13 production (GO:0032656) | 2.89285881 |
| 57 | cell proliferation involved in metanephros development (GO:0072203) | 2.87231199 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 2.86571317 |
| 59 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.86258019 |
| 60 | gamma-aminobutyric acid transport (GO:0015812) | 2.85627401 |
| 61 | cellular zinc ion homeostasis (GO:0006882) | 2.85270602 |
| 62 | indole-containing compound metabolic process (GO:0042430) | 2.84317121 |
| 63 | regulation of fibrinolysis (GO:0051917) | 2.83707212 |
| 64 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.83593149 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 2.81569196 |
| 66 | primary amino compound metabolic process (GO:1901160) | 2.80066690 |
| 67 | regulation of cilium movement (GO:0003352) | 2.78367918 |
| 68 | blood coagulation, intrinsic pathway (GO:0007597) | 2.78290673 |
| 69 | indolalkylamine metabolic process (GO:0006586) | 2.77314756 |
| 70 | regulation of T-helper cell differentiation (GO:0045622) | 2.76985018 |
| 71 | nephron epithelium morphogenesis (GO:0072088) | 2.76852827 |
| 72 | nephron tubule morphogenesis (GO:0072078) | 2.76852827 |
| 73 | acrosome reaction (GO:0007340) | 2.75511116 |
| 74 | negative regulation of telomere maintenance (GO:0032205) | 2.74878750 |
| 75 | reverse cholesterol transport (GO:0043691) | 2.71974919 |
| 76 | peristalsis (GO:0030432) | 2.71792283 |
| 77 | response to prostaglandin (GO:0034694) | 2.71516844 |
| 78 | negative regulation of astrocyte differentiation (GO:0048712) | 2.70296150 |
| 79 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.69645473 |
| 80 | neuronal action potential (GO:0019228) | 2.68633218 |
| 81 | sperm capacitation (GO:0048240) | 2.68007505 |
| 82 | modified amino acid transport (GO:0072337) | 2.67142982 |
| 83 | amine catabolic process (GO:0009310) | 2.64812725 |
| 84 | cellular biogenic amine catabolic process (GO:0042402) | 2.64812725 |
| 85 | 2-oxoglutarate metabolic process (GO:0006103) | 2.64594114 |
| 86 | basic amino acid transport (GO:0015802) | 2.63822078 |
| 87 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.62745351 |
| 88 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.62714154 |
| 89 | cholesterol efflux (GO:0033344) | 2.62092694 |
| 90 | negative regulation of sterol transport (GO:0032372) | 2.62026636 |
| 91 | negative regulation of cholesterol transport (GO:0032375) | 2.62026636 |
| 92 | sperm-egg recognition (GO:0035036) | 2.61760667 |
| 93 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.61734783 |
| 94 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.61734783 |
| 95 | serotonin metabolic process (GO:0042428) | 2.61462077 |
| 96 | negative regulation of T cell differentiation (GO:0045581) | 2.59205529 |
| 97 | sleep (GO:0030431) | 2.57636659 |
| 98 | positive regulation of T cell mediated immunity (GO:0002711) | 2.57273121 |
| 99 | negative regulation of insulin receptor signaling pathway (GO:0046627) | 2.56552062 |
| 100 | multicellular organism reproduction (GO:0032504) | 2.56379942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.75212057 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.87012245 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.69712458 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.55505467 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.39606695 |
| 6 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.27013263 |
| 7 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.20377856 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.14261397 |
| 9 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.03215382 |
| 10 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.92559075 |
| 11 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92559075 |
| 12 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76359851 |
| 13 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.73943741 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73219640 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64632278 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64032323 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.62278615 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62158118 |
| 19 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57319131 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.56147750 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53497500 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52965314 |
| 23 | FUS_26573619_Chip-Seq_HEK293_Human | 1.52385884 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47525594 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46049843 |
| 26 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42552256 |
| 27 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42481005 |
| 28 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42481005 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39150991 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36455086 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35262133 |
| 32 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.33887554 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33502228 |
| 34 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.33490964 |
| 35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33135314 |
| 36 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.32596111 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30061463 |
| 38 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28003144 |
| 39 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25932268 |
| 40 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25635609 |
| 41 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24387579 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24237061 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.21657389 |
| 44 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21019562 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20675660 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19880154 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.19783123 |
| 48 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19559684 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17956861 |
| 50 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17230252 |
| 51 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16995082 |
| 52 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.16969158 |
| 53 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16729384 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16723457 |
| 55 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16234234 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16074192 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.15848713 |
| 58 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13390125 |
| 59 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.13241241 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13059513 |
| 61 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12256032 |
| 62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10837003 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10393997 |
| 64 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10393997 |
| 65 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.09851775 |
| 66 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08424437 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.06780646 |
| 68 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.06055081 |
| 69 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05518020 |
| 70 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05486518 |
| 71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.04408750 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04386908 |
| 73 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04386908 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03525875 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03130991 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02739195 |
| 77 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01166086 |
| 78 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00876371 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00376391 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00088686 |
| 81 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98393248 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97606775 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97219884 |
| 84 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96866401 |
| 85 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.96704567 |
| 86 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96554443 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95882719 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95882719 |
| 89 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.95598479 |
| 90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95586763 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95140975 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.95106511 |
| 93 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94282398 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.94246003 |
| 95 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.93867848 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.93741869 |
| 97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.93446454 |
| 98 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93014010 |
| 99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92953571 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92405743 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 4.40429623 |
| 2 | MP0002736_abnormal_nociception_after | 3.35683331 |
| 3 | MP0000569_abnormal_digit_pigmentation | 3.35107039 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.13952492 |
| 5 | MP0003195_calcinosis | 3.11242503 |
| 6 | MP0002254_reproductive_system_inflammat | 3.02392938 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.01799275 |
| 8 | MP0003878_abnormal_ear_physiology | 3.01799275 |
| 9 | MP0005645_abnormal_hypothalamus_physiol | 3.01296663 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.97663339 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61853219 |
| 12 | MP0000566_synostosis | 2.54677365 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.51395738 |
| 14 | MP0003136_yellow_coat_color | 2.47243097 |
| 15 | MP0005365_abnormal_bile_salt | 2.42539149 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.26953461 |
| 17 | MP0005360_urolithiasis | 2.20723219 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.17081485 |
| 19 | MP0004043_abnormal_pH_regulation | 2.10611546 |
| 20 | MP0004885_abnormal_endolymph | 2.08694585 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.94078015 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.90422735 |
| 23 | MP0004742_abnormal_vestibular_system | 1.89165450 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.87686461 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.81152528 |
| 26 | MP0001346_abnormal_lacrimal_gland | 1.77418354 |
| 27 | MP0003252_abnormal_bile_duct | 1.74406383 |
| 28 | MP0003646_muscle_fatigue | 1.70023253 |
| 29 | MP0003698_abnormal_male_reproductive | 1.69941527 |
| 30 | MP0003879_abnormal_hair_cell | 1.63547664 |
| 31 | MP0005671_abnormal_response_to | 1.62356520 |
| 32 | MP0002822_catalepsy | 1.57129492 |
| 33 | MP0001905_abnormal_dopamine_level | 1.44535492 |
| 34 | MP0005670_abnormal_white_adipose | 1.43815167 |
| 35 | MP0005332_abnormal_amino_acid | 1.42594105 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.42125849 |
| 37 | MP0003941_abnormal_skin_development | 1.39305161 |
| 38 | MP0001485_abnormal_pinna_reflex | 1.39056558 |
| 39 | MP0003638_abnormal_response/metabolism_ | 1.37172397 |
| 40 | MP0003868_abnormal_feces_composition | 1.37000448 |
| 41 | MP0001929_abnormal_gametogenesis | 1.32223083 |
| 42 | MP0005187_abnormal_penis_morphology | 1.31389791 |
| 43 | MP0008872_abnormal_physiological_respon | 1.27388743 |
| 44 | MP0003122_maternal_imprinting | 1.22006776 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.21363445 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.20510720 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.19284565 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.18124181 |
| 49 | MP0009745_abnormal_behavioral_response | 1.17744667 |
| 50 | MP0000534_abnormal_ureter_morphology | 1.17170306 |
| 51 | MP0001765_abnormal_ion_homeostasis | 1.14151328 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.13907433 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.10074472 |
| 54 | MP0002160_abnormal_reproductive_system | 1.08895936 |
| 55 | MP0001873_stomach_inflammation | 1.04605313 |
| 56 | MP0009785_altered_susceptibility_to | 1.04433808 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.04143885 |
| 58 | MP0009046_muscle_twitch | 1.03578908 |
| 59 | MP0003329_amyloid_beta_deposits | 1.02691693 |
| 60 | MP0002161_abnormal_fertility/fecundity | 1.02548369 |
| 61 | MP0001486_abnormal_startle_reflex | 0.99462134 |
| 62 | MP0002272_abnormal_nervous_system | 0.97686540 |
| 63 | MP0003303_peritoneal_inflammation | 0.97366632 |
| 64 | MP0005083_abnormal_biliary_tract | 0.92779986 |
| 65 | MP0004142_abnormal_muscle_tone | 0.91313255 |
| 66 | MP0006292_abnormal_olfactory_placode | 0.91291609 |
| 67 | MP0005448_abnormal_energy_balance | 0.91283065 |
| 68 | MP0002638_abnormal_pupillary_reflex | 0.88386924 |
| 69 | MP0009384_cardiac_valve_regurgitation | 0.87783645 |
| 70 | MP0002557_abnormal_social/conspecific_i | 0.86652973 |
| 71 | MP0005310_abnormal_salivary_gland | 0.83416037 |
| 72 | MP0000639_abnormal_adrenal_gland | 0.82905532 |
| 73 | MP0000427_abnormal_hair_cycle | 0.82460085 |
| 74 | MP0002938_white_spotting | 0.79755529 |
| 75 | MP0003633_abnormal_nervous_system | 0.79421362 |
| 76 | MP0002229_neurodegeneration | 0.78597712 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.77994083 |
| 78 | MP0002064_seizures | 0.77250015 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.75978816 |
| 80 | MP0000026_abnormal_inner_ear | 0.75889933 |
| 81 | MP0005636_abnormal_mineral_homeostasis | 0.75741782 |
| 82 | MP0001970_abnormal_pain_threshold | 0.74476405 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.73615389 |
| 84 | MP0008569_lethality_at_weaning | 0.73230748 |
| 85 | MP0001963_abnormal_hearing_physiology | 0.70893935 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.70567517 |
| 87 | MP0009840_abnormal_foam_cell | 0.69835147 |
| 88 | MP0009278_abnormal_bone_marrow | 0.69613301 |
| 89 | MP0000604_amyloidosis | 0.68985185 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.68815240 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 0.68723142 |
| 92 | MP0005389_reproductive_system_phenotype | 0.68036409 |
| 93 | MP0003631_nervous_system_phenotype | 0.67695578 |
| 94 | MP0008995_early_reproductive_senescence | 0.66125773 |
| 95 | MP0001664_abnormal_digestion | 0.65676901 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.65114505 |
| 97 | MP0002876_abnormal_thyroid_physiology | 0.64453996 |
| 98 | MP0000609_abnormal_liver_physiology | 0.61958271 |
| 99 | MP0002210_abnormal_sex_determination | 0.60873183 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.59387560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.30718302 |
| 2 | Enlarged epiphyses (HP:0010580) | 4.01741985 |
| 3 | Facial shape deformation (HP:0011334) | 3.91789625 |
| 4 | Potter facies (HP:0002009) | 3.91789625 |
| 5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.89574520 |
| 6 | Absent/shortened dynein arms (HP:0200106) | 3.89574520 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 3.81729696 |
| 8 | Glomerulonephritis (HP:0000099) | 3.72691085 |
| 9 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.45370545 |
| 10 | Nephritis (HP:0000123) | 3.36430748 |
| 11 | Conical tooth (HP:0000698) | 3.11794705 |
| 12 | Osteomalacia (HP:0002749) | 3.08518437 |
| 13 | Epidermoid cyst (HP:0200040) | 3.04561789 |
| 14 | Xanthomatosis (HP:0000991) | 2.93574631 |
| 15 | Hyperphosphaturia (HP:0003109) | 2.91416911 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 2.85114923 |
| 17 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.71945898 |
| 18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.71945898 |
| 19 | Progressive cerebellar ataxia (HP:0002073) | 2.67006460 |
| 20 | Spastic tetraparesis (HP:0001285) | 2.57213663 |
| 21 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.46337912 |
| 22 | Abnormal urine phosphate concentration (HP:0012599) | 2.45272448 |
| 23 | Vascular calcification (HP:0004934) | 2.44237238 |
| 24 | Hypophosphatemic rickets (HP:0004912) | 2.42070181 |
| 25 | Midline defect of the nose (HP:0004122) | 2.41488779 |
| 26 | Tubulointerstitial abnormality (HP:0001969) | 2.38574637 |
| 27 | Tubulointerstitial fibrosis (HP:0005576) | 2.34912592 |
| 28 | Complement deficiency (HP:0004431) | 2.33901081 |
| 29 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33313787 |
| 30 | Supernumerary spleens (HP:0009799) | 2.31731052 |
| 31 | Joint hemorrhage (HP:0005261) | 2.31408985 |
| 32 | Spontaneous abortion (HP:0005268) | 2.27485143 |
| 33 | Attenuation of retinal blood vessels (HP:0007843) | 2.26797297 |
| 34 | Metabolic alkalosis (HP:0200114) | 2.24006235 |
| 35 | Abnormal urine output (HP:0012590) | 2.22231789 |
| 36 | Hypoplastic ischia (HP:0003175) | 2.21301469 |
| 37 | Delayed CNS myelination (HP:0002188) | 2.20961500 |
| 38 | Stage 5 chronic kidney disease (HP:0003774) | 2.18981191 |
| 39 | Abnormality of the pubic bones (HP:0003172) | 2.18276052 |
| 40 | Tongue fasciculations (HP:0001308) | 2.17374860 |
| 41 | Abnormal ciliary motility (HP:0012262) | 2.17221528 |
| 42 | Trigonocephaly (HP:0000243) | 2.16699303 |
| 43 | Agitation (HP:0000713) | 2.14653504 |
| 44 | Tubular atrophy (HP:0000092) | 2.14082785 |
| 45 | Pancreatic cysts (HP:0001737) | 2.13547105 |
| 46 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.12414251 |
| 47 | Progressive hearing impairment (HP:0001730) | 2.09819217 |
| 48 | Gingival bleeding (HP:0000225) | 2.06430045 |
| 49 | Neoplasm of the heart (HP:0100544) | 2.06339310 |
| 50 | Muscle fibrillation (HP:0010546) | 1.99737246 |
| 51 | Hyperalaninemia (HP:0003348) | 1.99364650 |
| 52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99364650 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 1.99364650 |
| 54 | Cardiovascular calcification (HP:0011915) | 1.98580860 |
| 55 | Hypokalemic alkalosis (HP:0001949) | 1.97507413 |
| 56 | Back pain (HP:0003418) | 1.96586099 |
| 57 | Tubulointerstitial nephritis (HP:0001970) | 1.96270711 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 1.95758654 |
| 59 | Optic neuritis (HP:0100653) | 1.95758654 |
| 60 | Hypercholesterolemia (HP:0003124) | 1.93993426 |
| 61 | Anomalous pulmonary venous return (HP:0010772) | 1.92579522 |
| 62 | Genetic anticipation (HP:0003743) | 1.92340564 |
| 63 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89548027 |
| 64 | Keratoconjunctivitis (HP:0001096) | 1.87441465 |
| 65 | Tinnitus (HP:0000360) | 1.86710418 |
| 66 | Proximal tubulopathy (HP:0000114) | 1.85661678 |
| 67 | Nephronophthisis (HP:0000090) | 1.85520635 |
| 68 | Focal segmental glomerulosclerosis (HP:0000097) | 1.85262219 |
| 69 | Abnormality of renal excretion (HP:0011036) | 1.84203365 |
| 70 | Supernumerary ribs (HP:0005815) | 1.81269300 |
| 71 | Increased IgE level (HP:0003212) | 1.79044309 |
| 72 | True hermaphroditism (HP:0010459) | 1.78628579 |
| 73 | Arthropathy (HP:0003040) | 1.76984613 |
| 74 | Abnormality of the ischium (HP:0003174) | 1.76773247 |
| 75 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.76529965 |
| 76 | Broad palm (HP:0001169) | 1.76454635 |
| 77 | Abnormality of macular pigmentation (HP:0008002) | 1.76156113 |
| 78 | Amyloidosis (HP:0011034) | 1.75024816 |
| 79 | Abnormality of the renal cortex (HP:0011035) | 1.74666609 |
| 80 | Renovascular hypertension (HP:0100817) | 1.74250045 |
| 81 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.74083787 |
| 82 | Abnormality of urine glucose concentration (HP:0011016) | 1.74029780 |
| 83 | Glycosuria (HP:0003076) | 1.74029780 |
| 84 | Widely patent fontanelles and sutures (HP:0004492) | 1.73991775 |
| 85 | Abnormality of cochlea (HP:0000375) | 1.72859196 |
| 86 | Abnormality of the renal medulla (HP:0100957) | 1.72603828 |
| 87 | Acanthocytosis (HP:0001927) | 1.71829725 |
| 88 | Prominent supraorbital ridges (HP:0000336) | 1.71754058 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.71340252 |
| 90 | Glomerulosclerosis (HP:0000096) | 1.71233415 |
| 91 | Opisthotonus (HP:0002179) | 1.71187931 |
| 92 | Hemiplegia (HP:0002301) | 1.70764384 |
| 93 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.69990152 |
| 94 | Hydroxyprolinuria (HP:0003080) | 1.67575267 |
| 95 | Abnormality of proline metabolism (HP:0010907) | 1.67575267 |
| 96 | Hyperlipoproteinemia (HP:0010980) | 1.67357823 |
| 97 | Congenital stationary night blindness (HP:0007642) | 1.65426732 |
| 98 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.63666720 |
| 99 | Abnormality of the sella turcica (HP:0002679) | 1.63047859 |
| 100 | Restlessness (HP:0000711) | 1.62756358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 2.77571094 |
| 2 | RIPK4 | 2.42973798 |
| 3 | PNCK | 2.17082298 |
| 4 | TLK1 | 2.14955531 |
| 5 | MAP4K2 | 13.6793015 |
| 6 | MAPK15 | 1.92439329 |
| 7 | TXK | 1.65578893 |
| 8 | ACVR1B | 1.62062935 |
| 9 | GRK6 | 1.53699382 |
| 10 | BCKDK | 1.47003946 |
| 11 | TYRO3 | 1.40400554 |
| 12 | WNK4 | 1.29626767 |
| 13 | BMPR1B | 1.27901538 |
| 14 | OXSR1 | 1.27424689 |
| 15 | DDR2 | 1.23313454 |
| 16 | ICK | 1.21314709 |
| 17 | CAMK1D | 1.12166569 |
| 18 | MAP3K11 | 1.04783632 |
| 19 | STK39 | 1.03547378 |
| 20 | ADRBK2 | 1.03295253 |
| 21 | CAMK1G | 1.00288859 |
| 22 | PLK4 | 0.99409371 |
| 23 | CDK3 | 0.92715476 |
| 24 | IRAK1 | 0.92119188 |
| 25 | CAMKK2 | 0.90708504 |
| 26 | FGFR3 | 0.89601731 |
| 27 | EPHA3 | 0.88124128 |
| 28 | TAOK3 | 0.87656251 |
| 29 | MAP3K4 | 0.85495980 |
| 30 | ZAK | 0.81010709 |
| 31 | YES1 | 0.78640520 |
| 32 | PDK1 | 0.73168559 |
| 33 | MAPK13 | 0.72025762 |
| 34 | FGFR4 | 0.71264511 |
| 35 | CDK19 | 0.68858443 |
| 36 | INSRR | 0.65580009 |
| 37 | TBK1 | 0.65545252 |
| 38 | MATK | 0.62316200 |
| 39 | CDK8 | 0.60286581 |
| 40 | PRKCG | 0.59093420 |
| 41 | PRKCQ | 0.58236897 |
| 42 | STK38L | 0.57712841 |
| 43 | CSNK1A1L | 0.57260268 |
| 44 | KIT | 0.56613201 |
| 45 | CSNK1G2 | 0.56557097 |
| 46 | PDPK1 | 0.56299888 |
| 47 | CSK | 0.55835367 |
| 48 | TAOK2 | 0.55307911 |
| 49 | PRKCZ | 0.51556026 |
| 50 | CSNK1G3 | 0.50608310 |
| 51 | GRK7 | 0.50253075 |
| 52 | STK38 | 0.49443130 |
| 53 | CAMK1 | 0.47069525 |
| 54 | PDGFRB | 0.46506617 |
| 55 | CSNK1G1 | 0.46333501 |
| 56 | IKBKB | 0.44661807 |
| 57 | TAOK1 | 0.41804741 |
| 58 | MAP3K3 | 0.40904653 |
| 59 | ITK | 0.39974248 |
| 60 | DYRK1B | 0.36911291 |
| 61 | MAP3K14 | 0.36601103 |
| 62 | SYK | 0.36497887 |
| 63 | CAMK4 | 0.36406448 |
| 64 | PKN1 | 0.35327556 |
| 65 | FGFR1 | 0.34201495 |
| 66 | MAP3K7 | 0.33867950 |
| 67 | IKBKE | 0.31734701 |
| 68 | IRAK2 | 0.29593621 |
| 69 | PIM2 | 0.29377764 |
| 70 | CHUK | 0.29030520 |
| 71 | LYN | 0.28828789 |
| 72 | CDK7 | 0.28778500 |
| 73 | UHMK1 | 0.24320933 |
| 74 | NTRK2 | 0.22857342 |
| 75 | GRK1 | 0.20629799 |
| 76 | IGF1R | 0.19723043 |
| 77 | AKT3 | 0.19142799 |
| 78 | CDK12 | 0.18889679 |
| 79 | WEE1 | 0.18845431 |
| 80 | JAK3 | 0.18552958 |
| 81 | TEC | 0.18451505 |
| 82 | CAMK2A | 0.18340361 |
| 83 | SGK1 | 0.18267968 |
| 84 | PLK2 | 0.17622494 |
| 85 | ERBB2 | 0.17599423 |
| 86 | PRKACB | 0.17334421 |
| 87 | INSR | 0.17243272 |
| 88 | PRKACA | 0.17194606 |
| 89 | IRAK4 | 0.16973321 |
| 90 | MAP4K1 | 0.16853754 |
| 91 | MAPK11 | 0.16643714 |
| 92 | LCK | 0.16589821 |
| 93 | RPS6KA3 | 0.15699257 |
| 94 | TGFBR2 | 0.15029769 |
| 95 | CSNK1D | 0.14617692 |
| 96 | CAMK2B | 0.14313300 |
| 97 | PRKG1 | 0.14292224 |
| 98 | RET | 0.13449892 |
| 99 | ADRBK1 | 0.13120403 |
| 100 | PIK3CA | 0.13009436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.77808802 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63451640 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.61599515 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.44780911 |
| 5 | ABC transporters_Homo sapiens_hsa02010 | 2.43029873 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24722769 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.22854532 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.08526829 |
| 9 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.03244470 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.99997065 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96204801 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91163675 |
| 13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89634347 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.82856950 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.79651742 |
| 16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.74089863 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72875330 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.72357655 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66123233 |
| 20 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.65240802 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62078691 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.61373327 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.56975382 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.45673293 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43679544 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.43290753 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.43220333 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40990194 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38552599 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.29214537 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.28296192 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26621256 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25223541 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23977284 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.23123050 |
| 36 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22135029 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21561124 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21368613 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.19644332 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15867954 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.14121054 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.13179997 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.08183916 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07204737 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06925540 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06044157 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04189768 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03562308 |
| 49 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01692868 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98329705 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.95971703 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.92049556 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91133821 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87195728 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86058151 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85616315 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83895829 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80821773 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80696337 |
| 60 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79209797 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79200176 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.79163424 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79048417 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77219971 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.73775077 |
| 66 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.71845845 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70949586 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.69143534 |
| 69 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67631320 |
| 70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67366969 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66695764 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65052191 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64658478 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61934950 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.60447197 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55680776 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55459588 |
| 78 | Morphine addiction_Homo sapiens_hsa05032 | 0.54616567 |
| 79 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53832588 |
| 80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53327491 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51298100 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.51287874 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50138876 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.49763400 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47027249 |
| 86 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46439617 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43094515 |
| 88 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42850331 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41105490 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40602226 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39175789 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38487341 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36603842 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35198810 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33005890 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32752492 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32142929 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.30886268 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30403692 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.30108026 |

